Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Paterson

Showing results (61-70 of 574) with videos related to

Pageof 58
Sort By:
Current Opinion in Infectious Diseases|August 17, 2011
New Gram-positive antibiotics: better than vancomycin?Sebastiaan J van Hal, David L Paterson
Medicine|March 31, 2023
A contemporary case series of Pseudomonas aeruginosa infective endocarditisAndrew Walczak, Kate McCarthy, David L Paterson
International Health|August 29, 2024
Development and validation of supervised machine learning multivariable prediction models for the diagnosis of Pneumocystis jirovecii pneumonia using nasopharyngeal swab PCR in adults in a low-HIV prevalence settingRusheng Chew, Marion L Woods, David L Paterson
Antimicrobial Agents and Chemotherapy|June 28, 2006
Effect of a selective decontamination of the digestive tract regimen including parenteral cefepime on establishment of intestinal colonization with vancomycin-resistant Enterococcus spp. and Klebsiella pneumoniae in miceDavid L Paterson, Usha Stiefel, Curtis J Donskey
Antibiotics (Basel, Switzerland)|December 23, 2022
Next-Generation Polymyxin Class of Antibiotics: A Ray of Hope Illuminating a Dark RoadAbdullah Tarık Aslan, Murat Akova, David L Paterson
ASM Case Reports|November 17, 2025
<i>Stenotrophomonas maltophilia</i>: the need for randomized controlled trials to evaluate treatment optionsYa-Ting Chang, Luca Mezzadri, David L Paterson
Current Opinion in Infectious Diseases|August 31, 2010
Multiresistant Gram-negative infections: a global perspectiveJennifer Ho, Paul A Tambyah, David L Paterson
Genome Announcements|August 29, 2015
Draft Genome Sequences of Two IMP-4-Producing Escherichia coli Sequence Type 131 Isolates in AustraliaHanna E Sidjabat, Jennifer Robson, David L Paterson
Current Opinion in Critical Care|September 5, 2025
Management of MDR/XDR severe infections in the critically illLuca Mezzadri, Ya-Ting Chang, David L Paterson
Antimicrobial Agents and Chemotherapy|April 11, 2007
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumanniiAnton Y Peleg, Jennifer Adams, David L Paterson
Pageof 58

Showing results (61-70 of 574) with videos related to

Sort By:
Pageof 58
Current Opinion in Infectious Diseases|August 17, 2011
New Gram-positive antibiotics: better than vancomycin?Sebastiaan J van Hal, David L Paterson
Medicine|March 31, 2023
A contemporary case series of Pseudomonas aeruginosa infective endocarditisAndrew Walczak, Kate McCarthy, David L Paterson
International Health|August 29, 2024
Development and validation of supervised machine learning multivariable prediction models for the diagnosis of Pneumocystis jirovecii pneumonia using nasopharyngeal swab PCR in adults in a low-HIV prevalence settingRusheng Chew, Marion L Woods, David L Paterson
Antimicrobial Agents and Chemotherapy|June 28, 2006
Effect of a selective decontamination of the digestive tract regimen including parenteral cefepime on establishment of intestinal colonization with vancomycin-resistant Enterococcus spp. and Klebsiella pneumoniae in miceDavid L Paterson, Usha Stiefel, Curtis J Donskey
Antibiotics (Basel, Switzerland)|December 23, 2022
Next-Generation Polymyxin Class of Antibiotics: A Ray of Hope Illuminating a Dark RoadAbdullah Tarık Aslan, Murat Akova, David L Paterson
ASM Case Reports|November 17, 2025
<i>Stenotrophomonas maltophilia</i>: the need for randomized controlled trials to evaluate treatment optionsYa-Ting Chang, Luca Mezzadri, David L Paterson
Current Opinion in Infectious Diseases|August 31, 2010
Multiresistant Gram-negative infections: a global perspectiveJennifer Ho, Paul A Tambyah, David L Paterson
Genome Announcements|August 29, 2015
Draft Genome Sequences of Two IMP-4-Producing Escherichia coli Sequence Type 131 Isolates in AustraliaHanna E Sidjabat, Jennifer Robson, David L Paterson
Current Opinion in Critical Care|September 5, 2025
Management of MDR/XDR severe infections in the critically illLuca Mezzadri, Ya-Ting Chang, David L Paterson
Antimicrobial Agents and Chemotherapy|April 11, 2007
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumanniiAnton Y Peleg, Jennifer Adams, David L Paterson
Pageof 58